Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/6/2022
CDE Issues the Technical Guidelines for Preparing the Risk Analysis an...
1/6/2022
CDE Issues the Technical Guidelines for Pharmacokinetic Study of Patie...
1/6/2022
CDE Issues the Technical Guidance for Clinical Trial Protocols of Drug...
1/6/2022
CDE Issues the Technical Guidance for Clinical Research of Rare Diseas...
1/6/2022
NMPA Solicits Comments on the Draft of GMP's Cell Therapy Product Appe...
1/6/2022
JPO Announces Initial Year Procurement Volumes and Implementation Time...
1/5/2022
Junshi Biosciences Terminates Promotion Agreement with Astrazeneca
1/5/2022
3SBio's Sunshine Guojian and Syncromune Enter Co-development Deal for ...
1/5/2022
CDE Issues the Technical Guidance for Food Impacts in New Drug R&D Pro...
1/5/2022
CDE Issues the Guidelines for Clinical Studies of Crohn's Disease Drug...
1/5/2022
CDE Issues the Technical Guidelines for Clinical Trials of Ulcerative ...
1/5/2022
CDE Issues the Guidance Principles for Clinical Trials of Direct Antiv...
1/5/2022
Review of Sino-Foreign Drug Out-licensing Deals in 2021
1/5/2022
Review of Chinese Pharma In-licensing Deals in 2021
1/5/2022
SMEI: Chinese Urban Chemical Drug Hospital Market Rebounded 10% in 3Qs...
1/5/2022
China 2021: The NRDL Readout (PharmExec)
1/4/2022
CDE Issues on the Technical Guidelines for Writing Safety Reference In...
1/4/2022
NMPA Announces OTC Switch of Four Rx Drug Products
1/4/2022
Santhera Enters into Exclusive License Agreement with Sperogenix for V...
1/3/2022
Daewoong Submits BTX Product Nabota in China
1/3/2022
Hanmi Pharma Out-licenses Retinal Disease Drug to China's AffaMed
1/3/2022
Third Former GSK Scientist Pleads Guilty to Stealing Trade Secrets to ...
12/31/2021
CDE Issues Clarification for Implementation of ICH M9
12/31/2021
Long Winter Sets In for Both MNCs and Domestic Champions as 2021 NRDL ...
12/30/2021
Sirnaomics Launches IPO on the Main Board of Stock Exchange of Hong K...
12/30/2021
Ark Biopharma Enters Into License Deal with Commave for ADHD Drug Azst...
12/30/2021
Ant Group to Shut Down China's Largest Crowdfunded Healthcare Mutual ...
12/30/2021
NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...
12/30/2021
CDE Issues the Guiding Principles for Comprehensive Efficacy Analysis ...
12/30/2021
CDE Publicizes the List of Reference Formulations for GQCE Studies (54...
Page:
98
/
719
Total number of articles:
21546
:
[First]
[<<]
[96]
[97]
[98]
[99]
[100]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit